Non-Invasive Breast Tissue Diagnosis Using Optical Imaging Techniques
Diffuse Reflectance Spectroscopy and Photoacoustic Imaging
Led by Region Skane · Updated on 2026-04-29
90
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Breast cancer is a common cancer among women globally, and current diagnostic methods have limitations such as exposure to radiation and the need for invasive biopsies. Researchers are evaluating two optical imaging techniques, diffuse reflectance spectroscopy DRS and photoacoustic imaging PAI, to differentiate healthy, benign, and malignant breast tissues by identifying their unique optical profiles. This study aims to assess these methods as non-invasive, contrast-free alternatives to traditional imaging for breast cancer diagnosis or monitoring.
The study has three parts first, 30 breast tissue samples will be examined outside the body using DRS second, 30 samples will be examined ex-vivo using both DRS and PAI third, 30 participants will undergo in-vivo examination using PAI. The DRS device uses white light to generate optical signals, while PAI combines ultrasound with optical imaging to create functional images that may assess tissue oxygenation differences.
Participants will be evaluated through these imaging techniques to classify tissue types accurately. Outcomes include the number of subjects with correctly classified breast tissue using PAI and DRS, optical signal depth, and oxygenation levels in different tissue types. The study uses non-invasive imaging without ionizing radiation or contrast agents, with evaluations completed within days after imaging. Total participation time varies by study part.
CONDITIONS
Brief Title
Clinical Explorative Optical Breast Investigations
Research Team
S
Sophia Zackrisson, MD, PhD
N
Nadia Chaudhry, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Solitary malignant or benign biopsy verified tumor larger than 1 cm
Understands written and oral Swedish
You will not qualify if you...
Previous breast surgery
Has received neoadjuvant chemotherapy
Skin burns on the chest
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Single assessment day
Participants undergo non-invasive optical diagnostic tests including diffuse reflectance spectroscopy (DRS) and photoacoustic imaging (PAI) to analyze breast tissue types.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 30 days
Participants are observed to evaluate the accuracy of optical diagnostic techniques for breast tissue classification over time.
Follow-up assessments may occur within 30 days
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Risk Prediction Study for Patients with Structural, Rhythm, or Inflammatory Cardiovascular Diseases
Evaluating the Effects of Xuong Tan Lac Than Exercise on Joint Mobility and Muscle Endurance in Healthy Adults
Randomized Study Comparing Safety and Body Processing of MK-1406 Given as Two or Three Subcutaneous Injections in Healthy Adults
First-in-Human Study to Evaluate Safety, Tolerability, and Drug Behavior of MK-8644 in Healthy Adults and Patients With Mild to Moderate Plaque Psoriasis
Open-Label Study Evaluating How Nemtabrutinib Is Processed in People With Severe Kidney Disease
Study of Lysoveta Krill Oil Versus Placebo for Memory in Healthy Adults Aged 50 to 75 with Memory Concerns
Community Health Education Intervention to Promote Lung Cancer Screening and Reduce Cancer Burden in Western New York
Study Comparing Pain and Healing After Fractional Ablation Using DFG Laser Versus CO2 Laser on Upper Thighs
Study Comparing Muscle and Nerve Function in Adults Aged 60 to 85 Who Are Regular Exercisers or Untrained
Phase 1 Safety and Pharmacokinetics Study of ENC0653 Ointment Applied to Skin in Healthy Adults Aged 18 to 55
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Breast Cancer Diagnosis Using Extended-Wavelength-Diffuse Reflectance Spectroscopy (EW-DRS)-Proof of Concept in Ex Vivo Breast Specimens Using Machine Learning.